Lantern Pharma Inc. (LTRN) has 5 identified peers for comparison in the Healthcare sector. Peers include CUE, GBIO, IMNM, LYRA, TFFP.
LTRN has a market capitalization of $27.8M, compared to an average peer market cap of $429.84M. LTRN is notably smaller than its average peer.